Marijo Bilusic
16PUBLICATIONS
66CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (16)
Sort by Publication Date:
|Apr 06, 2026
The anti-obesogenic metabolite, Lac-Phe, is elevated by metformin treatment in prostate cancer patients.Marijo Bilusic, Durga Prasad Gannamedi, Bhipasha Challu
|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching
|Mar 03, 2025
Overcoming common emerging barriers to effective neoadjuvant immunotherapies.Sophia Sokol, Marijo Bilusic
|Oct 10, 2024
Stimulating Soluble Guanylyl Cyclase with the Clinical Agonist Riociguat Restrains the Development and Progression of Castration-Resistant Prostate Cancer.Ling Zhang, Clara I Troccoli, Beatriz Mateo-Victoriano
|Jan 14, 2023
A Phase I Single-Arm Study of Biweekly NHS-IL12 in Patients With Metastatic Solid Tumors.Margaret E Gatti-Mays, Nicholas P Tschernia, Julius Strauss
|Apr 27, 2022
What are the advantages of neoadjuvant immunotherapy over adjuvant immunotherapy?Marijo Bilusic
Pageof 3
Frequent Collaborators
10 joint publications
James L Gulley
8 joint publications
Ravi A Madan
6 joint publications
Jeffrey Schlom
5 joint publications
Fatima Karzai
4 joint publications
Caroline Jochems
3 joint publications
Charalampos S Floudas
3 joint publications
Lisa M Cordes
3 joint publications
Houssein Abdul Sater
2 joint publications
Jason Redman
2 joint publications
Margaret E Gatti-Mays
